Keyword: Novartis

Markets & Companies

Best Pharma Brands

08.09.2016 - Global brand agency Interbrand has identified the top 10 pharmaceutical brands among the top 25 global pharmaceutical companies. Besides the financial value of the brand, its...

News

Novartis Managers Guilty of Bribery in South Korea

17.08.2016 - South Korean prosecutors have indicted Novartis employees for bribing doctors in exchange for prescribing the company’s drugs. The Swiss drugmaker confirmed press reports that six...

News

High Drug Prices Said Pressuring US Medicare

26.07.2016 - Drugmakers who supply Medicare, the US health insurance for the elderly, are raking in billions of dollars for “pricey medications” at taxpayer expense, a report by the news agency...

News

Novartis Sticking With UK, Sees Lower US Prices

21.07.2016 - In presenting the company’s financial results for the second quarter of 2016, Joe Jimenez, CEO of Swiss drugmaker Novartis, took the opportunity to add comment on crucial issues...

News

Sandoz to Launch Five Biosimilars by 2020

21.06.2016 - Sandoz, the generics arm of Swiss drugmaker Novartis, has announced plans to launch five biosimilars of major oncology and immunology biologics across key global markets by 2020...

News

GSK Vaccines Head to Step Down

17.06.2016 - GlaxoSmithKline’s head of vaccines, Moncef Slaoui, has announced he will leave the company in June 2017 after nearly three decades at the company. Since joining GSK in 1998, Slaoui...

News

EU approves Novartis Drug for More Cancers

06.06.2016 - The European Commission has granted approval for Novartis’ Afinitor (everolimus) for treating unresectable or metastatic, well-differentiated non-functional neuroendocrine tumors...

News

Novartis Splits Pharmaceutical Division

19.05.2016 - Swiss drugmaker Novartis has announced plans to split its Pharmaceutical division into two business units, Novartis Pharmaceutical and Novartis Oncology. The first-mentioned will...